Arcus Biosciences
Lixia Jin has an extensive background in the field of DMPK, with experience spanning over two decades in various pharmaceutical companies such as Arcus Biosciences, Amgen, and Merck. Lixia holds a Ph.D. from the University of Washington and currently serves as the VP of DMPK at Arcus Biosciences.
This person is not in any offices
Arcus Biosciences
3 followers
Arcus Biosciences is a company creating new cancer therapeutics through the utilization of emerging insights in immunology. Arcus was formed in 2015 by a group of researchers from the biotechnology and pharmaceutical industries.